GlassScriptPhysician profile
Joseph M Casper
NPI 1689243297
$648.68
in general payments reported to CMS, 2019-2025
18 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.14 · 2023: $166 · 2024: $244 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $155.59 | 2023-2025 | Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $65.60 | 2024 | Voquezna |
| Amgen INC. | $64.06 | 2022-2025 | Otezla, Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.51 | 2023 | Lifevest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.10 | 2024 | Xifaxan, Trulance |
| Abbvie INC. | $30.17 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $29.89 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.19 | 2022 | |
| Inspire Medical Systems, INC. | $23.52 | 2024 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $22.14 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.04 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $19.03 | 2023 | Breztri |
| Sumitomo Pharma America, INC. | $17.89 | 2023 | Myfembree |
| Dynavax Technologies Corporation | $17.41 | 2022 | |
| Biogen, INC. | $16.94 | 2023 | Vumerity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.68 | 2023 | Shingrix |
| Janssen Pharmaceuticals, INC | $15.04 | 2024 | Xarelto |
| Exact Sciences Corporation | $13.88 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Casper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.